Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inflammatory bowel disease
Marketing
Durable IBD remission remains an unmet need: survey
Doctors want safer oral treatment options for IBD, according to a new paper from Nimbus Therapeutics and Back Bay Life Science Advisors.
Zoey Becker
Jul 24, 2026 2:07pm
AZ, Boehringer-Simcere, Daiichi and more—Fierce Pharma Asia
Jan 30, 2026 7:45am
J&J survey underscores the power of patient community in IBD
Nov 7, 2025 5:00pm
AbbVie taps Tyler James Williams for new IBD campaign
Oct 7, 2025 2:12pm
J&J pads Tremfya IBD offerings with subQ ulcerative colitis nod
Sep 22, 2025 11:01am
J&J's Tremfya picks up key FDA nod in Crohn's disease
Mar 20, 2025 7:56pm
